REYA
Live / Applied — First extension granted (statement of use) (as of 09 Mar 2026)
What this means for you
Not registered yet, but its 20 Aug 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97556940
- Mark type
- Stylized text
- Filed
- 20 Aug 2022
- Published for opposition
- 17 Dec 2024
- Attorney of record
- Ardelle St.George
Goods and services
- Class 005 — Pharmaceuticals: Medicinal preparations for the delivery of molecules and compounds transdermally, through the dermal or skin layer, and orally through sublingual tablets that deliver molecules through mucosal pathways and under the tongue to mitigate pain associated with a wide variety of ailments and health conditions
Owner
- REMY Biosciences, Inc., Newport Coast, CA, US
- REMY Biosciences, Inc., Newport Coast, CA, US
Prosecution history
- 09 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Mar 2026 — SOU EXTENSION 1 GRANTED
- 03 Dec 2025 — SOU EXTENSION 1 FILED
- 09 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Feb 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 17 Feb 2026 — NOTICE OF REVIVAL - E-MAILED
- 17 Feb 2026 — PETITION TO REVIVE-GRANTED
- 17 Feb 2026 — TEAS PETITION TO REVIVE RECEIVED
- 05 Jan 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 05 Jan 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Apr 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 08 Jan 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 17 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Dec 2024 — PUBLISHED FOR OPPOSITION